Ren Q, Li L, Su X, Hu X, et al. Cofrogliptin once every 2 weeks as add-on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 2024 Sep 23. doi: 10.1111/dom.15915.
PMID: 39308336